|
|
Article: Geron Receives Favorable Ruling in Nuclear Transfer Patent Interference.
- Article from:
- Business Wire
- Article date:
- January 15, 2004
CopyrightCOPYRIGHT 2004 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Business Editors/Health/Medical Writers
MENLO PARK, Calif.--(BUSINESS WIRE)--Jan. 15, 2004
Geron Corporation (Nasdaq:GERN) announced today that the Board of Patent Appeals and Interferences of the U.S. Patent and Trademark Office has issued a decision on motions filed in the patent interference proceeding between Geron and Infigen, Inc. of DeForest, Wisconsin. The decision upholds the patentability of all of Geron's claims and finds all of the Infigen claims to be unpatentable.
The interference is between a patent application licensed to Geron from the Roslin Institute and an Infigen patent application. Both applications claim patent rights to ...